A detailed history of Hollencrest Capital Management transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Hollencrest Capital Management holds 36,123 shares of EW stock, worth $2.45 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
36,123
Previous 36,121 0.01%
Holding current value
$2.45 Million
Previous $3.34 Million 28.57%
% of portfolio
0.1%
Previous 0.15%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$59.7 - $93.78 $119 - $187
2 Added 0.01%
36,123 $2.38 Million
Q1 2024

May 01, 2024

BUY
$72.54 - $95.56 $2.52 Million - $3.32 Million
34,691 Added 2425.94%
36,121 $3.45 Million
Q1 2023

May 16, 2023

BUY
$74.26 - $84.51 $93,641 - $106,567
1,261 Added 746.15%
1,430 $118,000
Q4 2022

Feb 06, 2023

BUY
$68.3 - $87.44 $11,542 - $14,777
169 New
169 $12,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Hollencrest Capital Management Portfolio

Follow Hollencrest Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.